The NIH Budget and the Future of Biomedical Research

Author:

Abstract
Federal funding for biomedical research in the United States has fueled discoveries that have advanced our understanding of human disease, led to novel and effective diagnostic tools and therapies, and made our research enterprise an international paragon. Although it was not the original intent, this investment, through the National Institutes of Health (NIH), has also become an essential source of support for academic medical centers, providing funds for faculty and staff salaries, operational expenses, and even capital improvements related to research that can no longer be supported by clinical income. Until approximately 20 years ago, clinical income often subsidized research, but managed care, increased scrutiny and efficiency in the management of clinical expenses, and reductions in federal support for teaching hospitals have rendered clinical margins insufficient to support the research mission. Although some may see institution building as an inappropriate use of NIH funds, a consistent, productive biomedical research enterprise requires a solid infrastructure.

This publication has 1 reference indexed in Scilit: